SELAS PHARMACIE ANTOINE LEGRAND : revenue, balance sheet and financial ratios

SELAS PHARMACIE ANTOINE LEGRAND is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in AIRAINES (80270), this company of category PME shows in 2023 a revenue of 3.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE ANTOINE LEGRAND (SIREN 814107728)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C 3 035 082 € 2 922 340 € N/C N/C N/C N/C N/C
Net income 142 616 € 148 138 € 222 084 € 223 821 € 224 627 € 235 596 € 192 262 € 169 357 €
EBITDA N/C 228 053 € 329 741 € N/C N/C N/C N/C N/C
Net margin N/C 4.9% 7.6% N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELAS PHARMACIE ANTOINE LEGRAND generates positive net income of 143 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 169 k€ -> 143 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

142 616 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 62%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

62.055%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.619%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

43.8%

Solvency indicators evolution
SELAS PHARMACIE ANTOINE LEGRAND

Sector positioning

Debt ratio
62.05 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average

In 2024, the debt ratio of SELAS PHARMACIE ANTOINE L... (62.05) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
56.62% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +8 pts over 3 years

In 2024, the financial autonomy of SELAS PHARMACIE ANTOINE L... (56.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
7.53 years 2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average +10 pts over 2 years

In 2023, the repayment capacity of SELAS PHARMACIE ANTOINE L... (7.53) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 132.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

132.601

Liquidity indicators evolution
SELAS PHARMACIE ANTOINE LEGRAND

Sector positioning

Liquidity ratio
132.6 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average

In 2024, the liquidity ratio of SELAS PHARMACIE ANTOINE L... (132.60) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
8.63x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent

In 2023, the interest coverage of SELAS PHARMACIE ANTOINE L... (8.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 274 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 552 days. Excellent situation: suppliers finance 278 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

274 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

552 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS PHARMACIE ANTOINE LEGRAND

Positioning of SELAS PHARMACIE ANTOINE LEGRAND in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS PHARMACIE ANTOINE LEGRAND is estimated at 1 991 024 € (range 1 386 518€ - 2 978 687€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1386k€ 1991k€ 2978k€
1 991 024 € Range: 1 386 518€ - 2 978 687€
NAF 5 année 2024

Valuation method used

Net Income Multiple
142 616 € × 14.0x = 1 991 025 €
Range: 1 386 518€ - 2 978 687€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE ANTOINE LEGRAND with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE ANTOINE LEGRAND

What is the revenue of SELAS PHARMACIE ANTOINE LEGRAND ?

The revenue of SELAS PHARMACIE ANTOINE LEGRAND in 2023 is 3.0 M€.

Is SELAS PHARMACIE ANTOINE LEGRAND profitable?

Yes, SELAS PHARMACIE ANTOINE LEGRAND generated a net profit of 143 k€ in 2024.

Where is the headquarters of SELAS PHARMACIE ANTOINE LEGRAND ?

The headquarters of SELAS PHARMACIE ANTOINE LEGRAND is located in AIRAINES (80270), in the department Somme.

Where to find the tax return of SELAS PHARMACIE ANTOINE LEGRAND ?

The tax return of SELAS PHARMACIE ANTOINE LEGRAND is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE ANTOINE LEGRAND operate?

SELAS PHARMACIE ANTOINE LEGRAND operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.